@media (max-width: 768px) {
                .image-container {
                    width: 100% !important;
                    float: none !important;
                    margin: 0 0 1rem 0 !important;
                }
            }
        



Image source: The Mo

McKesson (MCK) Q2 2027 Earnings Call Transcript

The Board of Directors of McKesson yesterday declared a regular dividend of 94 cents per share of common stock. The dividend will be payable on January 4, 2027, to shareholders of record on December 1, 2026.

Prosperity Bancshares today announced that its Board of Directors decl

Daily Dividend Report: MCK,PB,HII,QCOM,ROL

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Schwab U.S. Large-Cap Growth ETF (Symbol: SCHG) where we have detected an approximate $333.0 million dollar inflow -- that's a 0.5% increase week ove

Noteworthy ETF Inflows: SCHG, BKNG, SPGI, MCK

Key PointsThe arrangement is now in force through June 2032.

Why McKesson Stock Soared More Than 5% Higher Today

The company extended its existing partnership with a major pharmacy chain.

Shares of healthcare distributor and services company McKesson (NYSE:MCK) jumped 4.4% in the afternoon session after the company reached an agreement in principle to extend its pharmaceutical distribution partnership with CVS Health through June 2032.

Why McKesson (MCK) Stock Is Trading Up Today

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, hospital reference labs, nursing homes, hospice and home health care agencies, government facilities, and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

McKesson Corporation News